Valspodar-modulated chemotherapy in human ovarian cancer cells SK-OV-3 and MDAH-2774

Valspodar-modulated chemotherapy in human ovarian cancer cells SK-OV-3 and MDAH-2774

Overcoming drug resistance in ovarian cancer is the overarching goal in gynecologic oncology. One way to increase drug cytotoxicity without increasing the drug dose is to simultaneously apply multidrug resistance modulator. Valspodar is the second generation P-glycoprotein 1 modulator capable of re...

Full description

Bibliographic Details
Main Authors: Maciej Zalewski, Julita Kulbacka, Jolanta Saczko, Małgorzata Drag-Zalesinska, Anna Choromanska
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2019-08-01
Series:Biomolecules & Biomedicine
Subjects:
ovarian carcinoma
cisplatin
Valspodar
oxidative stress
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/4073

Internet

https://www.bjbms.org/ojs/index.php/bjbms/article/view/4073

Similar Items